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Despite numerous interventions and treatment options, the outcomes of traumatic brain injury 
(TBI) have improved little over the last three decades, which raises concern about the value of 
care in this patient population. We aimed to synthesize the evidence on 14 potentially low-value 
clinical practices in TBI care. Using umbrella review methodology, we identified systematic 
reviews evaluating the effectiveness of 14 potentially low-value practices in adults with acute 
TBI. We present data on methodological quality (AMSTAR-2), reported effect sizes and 
credibility of evidence (I to IV). The only clinical practice with evidence of benefit was 
therapeutic hypothermia (credibility of evidence II to IV). However, the most recent meta-
analysis on hypothermia based on high-quality trials suggested harm (credibility of evidence IV). 
Meta-analyses on platelet transfusion for patients on antiplatelet therapy were all consistent with 
harm but were statistically non-significant. For the following practices, effect estimates were 
consistently close to the null: CT in adults with mild TBI who are low-risk on a validated clinical 
decision rule; repeat CT in adults with mild TBI on anticoagulant therapy with no clinical 
deterioration; antibiotic prophylaxis for external ventricular drain placement; and decompressive 
craniectomy for refractory intracranial hypertension. We identified five clinical practices with 
evidence of lack of benefit or harm. However, evidence could not be considered to be strong for 
any clinical practice as effect measures were imprecise and heterogeneous, systematic reviews 
were often of low quality and most included studies had a high risk of bias.   
Protocol registration: PROSPERO: CRD42019132428 




Traumatic brain injury (TBI) is the main cause of mortality from injury in people under 45 years 
of age1 and leads to US$60 and €33 billion in medical costs in the USA2 and Europe3 each year. 
Moreover, outcomes following TBI have not improved significantly in the last four decades.4, 5 
Treatment options for TBI are multiple, but many lack robust evidence of their effectiveness.6, 7 
 
Low-value clinical practices, defined as ‘a test or procedure that is not supported by evidence 
and/or could expose patients to unnecessary harm’8-15 consume up to 30% of healthcare 
resources.9, 16 In the past decade, the medical community has turned towards the de-adoption of 
low-value practices as a promising means to reduce the strain on healthcare budgets, free-up 
resources and reduce harm to patients.17 Physicians report using low-value practices because of a 
lack of alternative treatment options, fear of legal consequences, and a lack of guidelines on low-
value care.15, 18 The Brain Trauma Foundation, among others, publishes guidelines on TBI care.19 
However, emphasis is on practices that should be adhered to rather than practices that should be 
avoided. Choosing Wisely publishes recommendations specifically targeting low-value practices, 
but few pertain to TBI care and many are based uniquely on expert consensus.11 A previous 
scoping review and expert consultation survey identified 14 potentially low-value clinical 
practices in acute TBI care.20 These practices represent potential targets for guidelines, overuse 
metrics and de-adoption interventions. However, before recommendations can be made, we need 
to synthesize the evidence base for these practices. The objective of the present study was to 





Given the multitude of systematic reviews available for the clinical practices identified as 
potentially low-value,20 we opted to conduct an umbrella review (a review of systematic 
reviews).21 Our umbrella review was conducted according to published guidelines.22-24 In the 
absence of reporting guidelines for umbrella reviews, we used applicable Preferred Reporting 
Items for Systematic Reviews and Meta-Analysis (PRISMA).25 The protocol was published26 and 
registered with the International Prospective Register of Systematic Reviews (PROSPERO: 
CRD42019132428). An ethics waiver was obtained from the CHU de Québec – Université Laval 
research ethics board. 
 
Eligibility criteria 
We considered systematic reviews of original studies evaluating the effectiveness of any of the 
14 clinical practices previously identified in a scoping review and expert consultation study 20 in 
acute TBI in adults (exclusively ≥ 16 years old or less than 20% <16 years old). We limited the 
search to systematic reviews published in English since 1990, in line with umbrella review 
guidelines.23, 24 The project steering committee comprising clinicians (two emergency physicians, 
seven critical care physicians, and one neurosurgeon), four methodologists, and three health 
system managers used the Population, Intervention, Comparator, Outcome and Study design 
(PICOS) framework to develop specific research questions for each of the 14 clinical practices 
(Additional file 1).20, 27 
 
We used the Cochrane definition to identify systematic reviews; we considered a review to be 
systematic if it clearly stated a set of objectives and reported explicit eligibility criteria, an 
 
extensive search strategy (a refined search strategy ran on MEDLINE or the Cochrane Library 
and at least one other database)28, 29 and reproducible methods to identify, select, and critically 
appraise the findings of the included systematic reviews.22 
 
Outcomes 
Primary and secondary outcomes were identified for each of the 14 clinical practices by the 
project steering committee and are described in PICOS format in Additional file 1. The most 
common were intracranial injury for diagnostic interventions and the Glasgow Outcome Scale 
(GOS) or the GOS-Extended (GOS-E) for therapeutic interventions. 
 
Search strategy 
We developed comprehensive literature search strategies separately for each clinical practice on 
consultation with an information specialist (see Additional file 2 for PubMed search strategies). 
We searched systematic reviews using the Cochrane Library, Excerpta Medica Database 
(EMBASE), Epistemonikos,30 Medical Literature Analysis and Retrieval System Online 
(MEDLINE) and the International Prospective Register of Systematic Reviews (PROSPERO)31 
from 1990 to up to six months prior to submission for publication. Using a snowball approach, 




We managed all citations with EndNote software (version X8.2, Clarivate Analytics, 2014). We 
identified and removed duplicates using electronic and manual screening.36 To ensure reliability 
when selecting studies for a given practice, two sets of 100 citations were independently 
 
evaluated and then discussed by the reviewers. Pairs of reviewers (PAT, LM, IF) independently 
screened all identified records using titles, abstracts and full texts, consecutively. Any 
disagreement was resolved through discussion between reviewers and, if necessary, consultation 
with a senior author (AFT). 
 
Data items and abstraction process 
Using a standardized data abstraction form piloted on a representative sample of 5 systematic 
reviews, pairs of experienced reviewers (PAT, LM, IF) independently extracted the following 
data: first author, title, year of publication, databases used and date of the last search; 
population(s), intervention(s), comparator(s), outcome(s) and study designs included; measures 
of association and their respective measures of heterogeneity; risk of bias in original studies; and 
GRADE rating, when available. Any disagreement was resolved through discussion between 
reviewers and, if necessary, consultation with a senior author (AFT). When information was 
unclear or unavailable, we contacted systematic review authors with up to three email attempts. 
 
Methodological quality assessment 
Two reviewers (PAT, LM) independently critically appraised the quality of systematic reviews 
using the Assessing the Methodological Quality of Systematic Reviews (AMSTAR-2) tool. 
Methodological quality was categorised as critically low, low, moderate or high.37 
 
Synthesis 
Results are presented according to current recommendations for umbrella reviews.38 For each 
low-value practice and each review, we present the number of studies according to their design, 
the sample size, the quality of the reviews (AMSTAR-2), measures of association for primary 
 
and secondary outcomes with their measures of heterogeneity, reported risk of bias for included 
studies, and reported strength of evidence (GRADE).26 As GRADE was only used in 6/44 
systematic reviews, we also evaluated evidence with credibility of evidence criteria used in 
previous umbrella reviews.39, 40 These criteria class evidence from meta-analyses into four 
categories: convincing (class I), highly suggestive (class II), suggestive (class III), weak (class 
IV) and non-significant (NS), based on statistical significance, sample size, heterogeneity and 
risk of bias. 
 
RESULTS 
Of 8,455 citations identified in the initial search, we assessed 212 full texts for eligibility (Figure 
1). Of these, 44 were deemed eligible and included in the synthesis (Additional file 3). Details of 
excluded systematic reviews are provided in Additional file 4. 
 
Description of included reviews  
At least one systematic review was identified for ten out of 14 targeted low-value practices 
(Table 1). Systematic reviews conducted within the last five years were available for nine clinical 
practices and meta-analyses were available for eight practices. The number of systematic reviews 
varied from one for plasma transfusion and neuromuscular blocking agents to 19 for 
hypothermia. Reviews on imaging mostly defined primary outcomes as intracranial injury, 
neurological deterioration or neurosurgical intervention, and their population as patients with 
mild or mild complicated TBI. Systematic reviews on therapeutic interventions mainly focussed 
on the GOS or GOS-Extended, mortality, or adverse events in patients with moderate to severe 
TBI. Most systematic reviews restricted their population of interest to adults but some included 
pediatric patients. Nine systematic reviews did not specify targeted study designs in their PICOS. 
 
In 20 other systematic reviews, only RCTs were included and in 14 both randomized controlled 
trials and observational studies were considered. 
 
Methodological quality of systematic reviews 
Of the 44 included systematic reviews, two41, 42 were rated high quality and eight43-50 moderate 
quality (Additional file 5). All but two reviews51, 5251 52(51, 52)[51,52][51, 52] used a 
comprehensive research strategy (95%), 17 (38%) established methods prior to the review and 
reported significant deviations from the study protocol, 34 (76%) used a satisfactory technique 
for reporting risk of bias, 20 (45%) accounted for risk of bias in individual studies when 
interpreting/discussing results, 33 out of the 34 reviews (97%) performing meta-analyses used 
appropriate analytic methods, and 20 (59%) investigated the presence of publication bias and 
discussed its potential impact on the results of meta-analyses. 
 
Synthesis of results 
Primary outcomes 
Diagnostic interventions 
We identified two reviews for CT in adults with mild TBI (both without meta-analyses),44, 53 but 
only one presented data allowing us to calculate point estimates for our primary outcome;44 less 
than 5% of patients who were classed as low-risk (any decision rule) had intracranial injury 
(Table 2). Sample sizes were large for studies using the Canadian CT Head Rule (CCHR), the CT 
in Head Injury Patients (CHIP) rule and National Emergency X-Radiography Utilization Study 
(NEXUS) rule, but none of the included studies were at low risk of bias. In adults with acute mild 
complicated TBI (abnormal initial CT) with no neurological deterioration, routine repeat CT 
detected progression of intracranial hemorrhage in around 20% of patients. Routine repeat head 
 
CT led to the detection of delayed intracranial in only 0.6% of adults with mild TBI on 
anticoagulant or antiplatelet therapy.54 
 
Therapeutic interventions 
We identified two systematic reviews with meta-analyses on platelet transfusion in adults with 
TBI on antiplatelet therapy, which suggested increased risk of mortality in patients receiving the 
intervention, but estimates were imprecise and all CIs included the null value.46, 55 The systematic 
review on antibiotic prophylaxis for basal skull fracture suggested that the intervention is 
associated with reduced odds of meningitis, but again the estimates were imprecise and covered 
the null value.47 A systematic review by the same group reported no benefit of antibiotic 
prophylaxis for external ventricular drain placement in severe TBI in terms of risk of infection.41 
We identified four systematic reviews with meta-analyses on seizure prophylaxis extended for 
more than one week after injury.48, 56-58 Odds ratio (OR) and risks ratio (RR) varied from 0.40 to 
1.28 across systematic reviews. The most widely studied drug, levetiracetam, was associated with 
a potential reduction in late seizures, but with confidence intervals (CI) covering the null value. 
Fifteen out of the nineteen systematic reviews identified for therapeutic hypothermia performed 
meta-analyses with the GOS as the primary outcome.42, 43, 49, 52, 59-69 OR/RRs varied between 0.61 
and 1.16 with 11 suggesting significant benefit (credibility of evidence 3 class II,42, 43, 69 three 
class III65, 67, 68 and 5 class IV42, 61-64) and one69 (the most recent) suggesting significant harm 
(class IV). In five meta-analyses on high-quality studies, OR/RR either covered the null value 
(n=3),49, 64, 65 suggested significant harm (n=1)69 or suggested significant benefit (n=1).42 Finally, 
we identified six systematic reviews on decompressive craniectomy,70-75 of which four presented 
quantitative synthesis on GOS.70, 71, 74, 75 All were based exclusively on RCTs but were of low or 
critically low quality and had highly heterogeneous point estimates (I2≥72%). Effect estimates 
 
were consistently close to one with CI covering the null value, suggesting no significant 
difference in outcome between intervention and control groups. 
 
Secondary outcomes 
Close to 0% of adults with mild TBI who were at low risk on a clinical decision rule for head CT 
required neurosurgical intervention (Additional file 6).44 Routine repeat head CT in mild 
complicated TBI without neurological deterioration led to a neurosurgical intervention in 
between 0.6 and 2.4% of patients,76-78 a change in clinical management in between 0.677 and 
3.9%78 and a change in intracranial pressure (ICP) monitoring in 1.2%.78 Less than 0.2% of 
adults with mild TBI on anticoagulant or antiplatelet therapy with a routine repeat CT required 
neurosurgical treatment or died in hospital.54 
 
Authors of the single systematic review on antibiotic prophylaxis in adults with basal skull 
fractures reported no reduction in all-cause or meningitis-related mortality.47 In, eight of the 15 
systematic reviews on hypothermia, a statistically significant reduction in the risk or odds of 
mortality was observed whereas one review observed an increase.43, 50, 61, 64, 65, 67-69 Five out of 
seven reviews that looked at pneumonia suggested higher risk/odds of this adverse event in adults 
receiving therapeutic hypothermia.49, 59, 64, 67, 69 All of the four systematic reviews on 
decompressive craniectomy looked at mortality;71, 73-75 three observed a statistically lower risk in 
the intervention group at 6 months.73-75 Finally, two systematic reviews on decompressive 
craniectomy observed significantly lower mean intracranial pressure and shorter length of stay in 




In this umbrella review on potentially low-value clinical practices in acute TBI care, the only 
clinical practices with any evidence of clinical benefit were routine repeat CT in mild 
complicated TBI (detection of progression of intracranial hemorrhage around 20%) and 
hypothermia (credibility of evidence II to IV). However, the most recent review for hypothermia 
based on high-quality trials suggested harm (credibility of evidence IV).69 Meta-analyses on 
antibiotic prophylaxis in basal skull fractures all reported effect estimates consistent with 
clinically significant benefit but were statistically non-significant.47 Meta-analyses on anti-
platelet transfusion for adults with acute TBI on antiplatelet therapy all reported effect estimates 
consistent with clinically significant harm but were again statistically non-significant.46, 55 For the 
following practices, effect estimates were consistently close to the null value suggesting no 
clinical benefit: CT in adults with mild TBI who are at low-risk on a validated clinical decision 
rule;44 repeat CT in adults with mild TBI on anticoagulant or antiplatelet therapy with no clinical 
deterioration;54 antibiotic prophylaxis for external ventricular drain placement;41 and 
decompressive craniectomy for patients with refractory intracranial hypertension.68, 71, 74, 75 
However, confidence intervals were all wide. 
 
Three clinical practices pertained to low-value imaging, which leads to increased costs, delays in 
care for other patients who require diagnostic imaging and is associated with an increased 
lifelong risk of cancer.79-81 The review on CT in adults with mild TBI suggested less than 5% of 
patients who are at low-risk on a validated clinical decision rule had intracranial injury and less 
than 0.04% required neurosurgical intervention.44 These results are in line with the inclusion of 
this practice as low-value in internationally recognized guidelines (National Institute for Health 
and Care Excellence [NICE], Choosing Wisely).11, 82 Less than 1% of adults with mild TBI on 
anticoagulant or antiplatelet therapy showed progression of hemorrhage on repeat CT or had poor 
 
outcomes.54 However, the only systematic review on the subject was of very low quality. 
Evidence of low-value care for routinely repeating head CT in mild complicated TBI was less 
convincing with around one in five patients showing progression of hemorrhage.76, 77, 83 This 
suggests the need to develop predictive models to more accurately identify patients at low risk of 
progression to avoid unnecessary repeat head CT scans in this population. It may also suggest 
that progression of intracranial hemorrhage is not the most clinically relevant outcome; repeat CT 
led to a change in clinical management (i.e. change in ICP monitoring, drug therapy or 
neurosurgical intervention based on CT results) in less than 4% of patients (secondary 
outcome).76-78 This observation also brings up the question of how our threshold of tolerance for 
false negatives should vary according to the severity of the consequences of missing a case. 
 
In terms of therapeutic interventions, evidence for platelet transfusion in adults on antiplatelet 
therapy suggested low-value care, with a non-significant increase in mortality in all systematic 
reviews.46, 55 Antiplatelet therapy was used in between 3% to 42% of these patients and given the 
adverse events associated with this practice, its de-adoption has the potential to improve patient 
outcomes in addition to freeing-up resources. However, reviews were based on retrospective 
cohorts and evidence was graded as very low in all cases. A systematic review of moderate 
quality based on RCTs suggested a possible beneficial effect of antibiotic prophylaxis in adults 
with basal skull fractures with or without CSF leakage with evidence of moderate strength 
according to GRADE.47 However, OR were imprecise with 95% CI covering the null value. The 
only review on antibiotic prophylaxis for external ventricular drain placement included one RCT 
which suggested no benefit in terms of infection incidence but this was based on a very imprecise 
pooled estimate and unclear risk of bias.41 Evidence on extended antiseizure prophylaxis was 
inconsistent; most point estimates suggested a protective effect, but all CI covered the null value. 
 
The review including the most RCTs (n=6; also with the highest methodological quality) 
observed a null effect and graded the evidence as very low regarding carbamazepine and 
phenytoin whereas the most recent review (critically low quality) observed a non-significant 
protective effect and graded evidence as high for levetiracetam and phenytoin.48  
 
For therapeutic hypothermia, multiple large RCTs have been conducted (the most comprehensive 
systematic review included 22 RCTs)69 and targeted populations and interventions have changed 
over the years. The latest high-profile trials evaluated therapeutic hypothermia in all adults 
admitted to the ICU after a closed TBI with ICP>20 mm Hg for at least 5 minutes after stage I 
treatments (Eurotherm3235 Trial)84 and prophylactic hypothermia in adults with severe TBI 
regardless of ICP prior to randomisation (POLAR-RCT).85 POLAR-RCT was not included in any 
systematic review we identified. Recruitment in the Eurotherm3235 Trial was stopped early since 
preliminary results suggested harm in the intervention arm (6-month mortality, hazard ratio: 1.45 
[95 % CI: 1.01-2.10]). Moreover, results from the POLAR-RCT were compatible neither with 
harm nor benefit on six-month GOS-E (RR: 0.99 [95 % CI: 0.82-1.19]) and six-month mortality 
(RR: 1.15 [95 % CI: 0.80-1.64]. In line with these two RCTs, the most recent meta-analyses on 
RCTs with a low risk of bias suggest that therapeutic hypothermia is associated with no benefit or 
harm.69 Among changes in these recent trials which may explain observed differences are the 
application of a normotherapy protocol in the control group.  
 
For decompressive craniectomy, point estimates for unfavorable outcome were close to the null 
value and statistically non-significant indicating no significant benefit of the intervention in terms 
of reduction in unfavorable outcome (GOS 1-4) at 6 months. Results are mostly driven by two 
large high-profile RCTs (DECRA86 and RESCUE-ICP87) that were both included in three of the 
 
four systematic reviews we identified. In the DECRA trial, decompressive craniectomy was 
conducted as a second-tier therapy; a statistically non-significant increase in unfavorable outcome 
at six months for the intervention group and no difference in mortality were observed. In the 
RESCUE-ICP trial, decompressive craniectomy was conducted as a third-tier therapy; the 
intervention group had significantly lower mortality at 6 months but no difference in unfavorable 
outcome was observed (gains in survival translated into more patients with severe disability). The 
systematic reviews we identified for this clinical practice had critical methodological flaws. Of 
note, Lu and colleagues75 considered the GOS-E at 6 months for DECRA but at 12 months for 
RESCUE-ICP whereas Tsaousi74 and Zhang73 considered a GOS-E of three and less as an 
unfavorable outcome, therefore considering upper severe disability as favorable. This led to an 
overestimation of the benefit of the intervention in both cases. Since the publication of DECRA 
and RESCUE-ICP, a consensus statement has been published recognizing the lack of evidence of 
effectiveness for improving patient outcome but recommending (based solely on consensus) 
decompressive craniotomy in specific situations, often dictated by physician gestalt and 
physician-family shared decision-making.88 
 
Limitations 
This review does have limitations which should be considered in the interpretation of results. 
First, to ensure the feasibility of the review, we restricted our search to the 14 low-value practices 
identified previously in a scoping review and expert consultation study,20 which may have led us 
to miss some low-value practices. However, given the exhaustive search strategy used in the 
scoping review and the fact that experts were asked to add any other practices they considered 
low-value, it is unlikely that important low-value practices have been missed. Second, by 
targeting systematic reviews rather than original studies, we may have missed some evidence. For 
 
three clinical practices, we did not identify any systematic reviews, namely ICU admission in 
adults with acute mild complicated TBI who are not on direct oral anticoagulants, neurosurgical 
consultation in adults with acute mild TBI with normal head CT and albumin administration in 
severe TBI. In addition, for plasma transfusion and neuromuscular blocking agents, all identified 
studies were qualitative. Furthermore, systematic reviews may not convey the most up-to-date 
evidence (there are substantial delays between conduct of primary studies and publication of 
systematic reviews). We did search for RCT published after the date of the last search of the most 
up-to-date systematic reviews; only the POLAR study was identified.85 Additionally, systematic 
reviews may not meet high quality standards; reviews on decompressive craniectomy all had 
critical methodological flaws.85 Fourth, meta-analysis results may not convey heterogeneity in 
effects, as indicated by the high heterogeneity of pooled estimates in many systematic reviews. 
For example, we may have missed differential effects of decompressive craniectomy as a second-
tier or third-tier therapy or of therapeutic hypothermia according to timing and target 
temperature. Unfortunately, low numbers of studies precluded subgroup analyses for these 
factors. Fifth, all included reviews/studies aimed to demonstrate effectiveness (superiority trials) 
and were therefore not designed to formulate conclusions on low-value care (i.e. lack of 
effectiveness or harm). For this, inferiority trials would be necessary. Finally, for feasibility 
reasons, we limited this umbrella review to systematic reviews published in English since 1990 
as per recommendations for umbrella reviews.23, 24 These limitations should have a negligible 
impact on results since no systematic reviews were published prior to 1990 (the first review 
identified was published in 2001) and most published reviews are written in English.23, 24 Among 
the 23 studies excluded based on language, only two were eligible based on the English abstract 
(published in Mandarin and Romanian) and their reported results (again from the abstract) were 




We found low-grade evidence that the following clinical practices are either not beneficial or 
harmful: CT in adults with mild TBI who are at low-risk on a clinical decision rule; repeat CT for 
adults with mild TBI on anticoagulant or antiplatelet therapy prior to injury; platelet transfusions 
in adults on antiplatelet therapy; antibiotic prophylaxis for external ventricular drain placement; 
and decompressive craniectomy in patients with refractory intracranial hypertension. In addition, 
the most recent systematic review on high quality trials suggest that hypothermia is associated 
with harm when compared to normothermia. More rigorous evaluations will be needed to draw 
strong conclusions on the value of these practices. We should also strive to measure the 
prevalence of these practices and assess inter-provider variation. Conditional on the results of 
future research, they may represent targets for de-adoption interventions to improve value in care 
for adults with acute TBI. The reduction of low-value clinical practices in this patient population 
has the potential to reduce pressure on strained healthcare budgets, free up resources, reduce 
adverse events and improve patient outcomes. 
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Table 2. Synthesis of results for diagnostic interventions 
First author and year of 











χ2, Q or I2 
Studies at low 
risk of bias, nc 
 
Head CT in adults with acute mild TBI at low-risk on a validated clinical decision rule 
Intracranial injury 
Pandor et al. 2011 
CCHR (high risk criteria) 
CHIP 
New Orleans Criteria 
NEXUS-II 
 
0; 5; 1; 0 
0; 1; 0; 0 
0; 5; 1; 0 










0 to 4.52%g 
1.21% g 
0 to 2.89% g 









Routine repeat head CT in absence of neurological deterioration in adults with acute mild complicated TBI
e 
Progression of intracranial traumatic hemorrhage on repeat CT 
Stippler et al. 2012 0; 8; 7; 4 1,630 Critically low 19.9%h NR 0/19 
Almenawer et al. 2013 0; 8; 4; 0 2,120 Critically low 22.4%g NR NR 
Marincowitz et al. 2018 0; 2; 12; 0 NR Critically low 20.4% (14.7-26.7) I2=97.9% NR 
Routine repeat head CT in absence of neurological deterioration in adults with acute mild TBI on anticoagulant or antiplatelet therapy
f
 
Delayed intracranial hemorrhage 
Chauny et al. 2016 0; 3; 4; 0 1,594 Critically low 0.6% (0.0-1.2) NR 0/7 
AMSTAR, Assessing the Methodological Quality of Systematic Reviews; CCHR, Canadian CT Head Rule; CHIP, CT in Head Injury Patients; CI, confidence 
intervals; CT, computed tomography; NA, not applicable; NEXUS-II, the National Emergency X-Radiography Utilisation Study II; NR, not reported; P, 
proportion; RCT, randomized controlled trials; TBI, traumatic brain injury 
aInterpretation of AMSTAR-2: High: no or one non-critical weakness, Moderate: more than one non-critical weakness, Low: one critical flaw with or without non-
critical weaknesses, Critically low: more than one critical flaw with or without non-critical weaknesses 
bFalse omission rate, calculated as «1 – negative predictive value (i.e., true negatives / [true negatives + false negatives])» 
cAs reported in systematic review 
dNumber of studies ≥ 70% items 
eMild TBI with abnormal initial head CT 
fMild TBI with normal initial head CT 
gRange of values from included studies 
hPooled estimate from included studies (CI not reported) 
 
 
Table 3. Synthesis of results for therapeutic interventions 
 
First author and year of 








AMSTAR-2a OR or RR 















Platelet transfusion in adults with acute traumatic brain injury on antiplatelet therapy 
Mortality 




0; 0; 5; 0 




Moderate   
OR: 1.55 (0.75-3.18) 








Very low; NS 
Very low; NS 
Leong et al. 2015 0; 0; 4; 0 711 Critically low OR: 1.77 (1.00-3.13) I2=36% 2/4d NR; NS 
Antibiotic prophylaxis in adults with basal skull fractures 
Meningitis 
Ratilal et al. 2015 
With CSF leakage 
Without CSF leakage 
 
3; 0; 0; 0 




Moderate   
OR: 0.44 (0.09-2.15) 









Moderate; NS  
Antibiotic prophylaxis for external ventricular drain placement in adults with acute traumatic brain injury 
Infections 
Ratilal et al. 2010 1; 0; 0; 0 52 High  OR: 1.08 (0.06-18.3) NA NR NR; NS 
Extended seizure prophylaxis >1 week in adults with severe TBI 
Late seizurese 







1; 0; 0; 0 
1; 0; 0; 0 
1; 0; 0; 0 
4; 0; 0; 0 







Critically low    
RR: 0.70 (0.33-1.50) 
RR: 0.45 (0.12-1.73) 
RR: 0.36 (0.08-1.73) 
RR: 1.08 (0.76-1.55) 













Chang et al. 2003 
Carbamazepine+phenytoi
n+valproate 
5; 0; 0; 0 1,312 Critically low RR: 1.05 (0.82-1.35) NR 2/5 NR; NS 
Thompson et al. 2015 
Carbamazepine+phenytoin  
6; 0; 0; 0 1,029 Moderate RR: 0.91 (0.57-1.47) I2=54% 2/6d Very low; NS 




2; 0; 0; 0 




Critically low  
OR: 0.69 (0.24-1.96) 










Therapeutic hypothermia in adults with acute severe traumatic brain injury  
 
GOS or GOS-E – unfavorable outcome 
 
Harris et al. 2002 4; 0; 0; 0 499 Critically low  OR: 0.61 (0.26-1.46) χ2=6.9 0/4 NR; NS 
Henderson et al. 2003 8; 0; 0; 0 748 Critically low OR: 0.75 (0.56-1.10) χ2=16.6 3/8 NR; NS 
McIntyre et al. 2003 10; 0; 0; 0 779 Low RR: 0.78 (0.63-0.98) Q=16.1 2/10 NR; IV 
Bratton et al. 2007 6; 0; 0; 0 694 Critically low RR: 0.68 (0.52-0.89) I2=48% 0/6f NR; IV 
Peterson et al. 2008 12; 0; 0; 0 1,294 Low RR: 0.73 (0.59-0.90) I2=59% 1/12 NR; IV 
Sydenham et al. 2009 
All studies 
Low risk of bias 
 
20; 0; 0; 0 





OR: 0.69 (0.55-0.86) 










Fox et al. 2010 10; 0; 0; 0 1,223 Moderate RR: 0.66 (0.56-0.78) I2=34% 7/10 II 
Georgiou et al. 2013 
All studies 
Low risk of bias 
 
18; 0; 0; 0 





RR: 0.81 (0.73-0.89) 










Crossley et al. 2014 
All studies 
Low risk of bias 
 
20; 0; 0; 0 





RR: 0.67 (0.78-0.57) 










Li et al. 2014 10; 1; 0; 0 1,029 Critically low RR: 0.83 (0.65-1.05) I2=61% NR NR; NS 
Zhu et al. 2016 
All studies 
Low risk of bias 
 
11; 0; 0; 0 





RR: 0.80 (0.63-1.00) 










Crompton et al. 2017 20; 14; 1; 0 3,109 Critically low RR: 0.74 (0.65-0.85) I2=53% NR NR; III 
Leng et al. 2017 7; 0; 0; 0 1,324 Critically low OR: 1.00 (0.79-1.21) I2=68% NR NR; NS 
Zang et al. 2017 21; 0; 0; 0 2,302 Critically low RR: 0.71 (0.60-0.84) I2=72% 10/21 NR; III 
Watson et al. 2018 
All studies 
Low risk of bias 
 
22; 0; 0; 0 





RR: 0.81 (0.75-0.87) 










Decompressive craniectomy in adults with severe traumatic brain injury 
GOS/GOS-E – unfavorable outcome 
Wang et al. 2016 2; 0; 0; 0 175 Critically low  RR: 0.89 (0.34-2.37) I2=81% 1/2 NR; NS 
Zhang et al. 2017 4; 0; 0; 0 645 Critically low RR: 0.85 (0.61-1.18) I2=73% 2/4 NR; NS 
Tsaousi et al. 2018 3; 0; 0; 0 564 Low RR: 0.94 (0.63-1.41) I2=75% 2/3 NR; NS 
Lu et al. 2019 4; 0; 0; 0 622 Critically low OR: 0.75 (0.32-1.75) I2=77% 0/4 NR; NS 
 
AMSTAR, Assessing the Methodological Quality of Systematic Reviews; CI, confidence intervals; CSF, cerebrospinal fluid; CT, computed tomography; GOS-
E, Glasgow Outcome Scale-Extended; GRADE, Grading of Recommendations Assessment, Development and Evaluation; NA, not applicable; NEXUS-II, the 
National Emergency X-Radiography Utilisation Study II; NR, not reported; OR, odds ratio; P, proportion; RR, relative risks; RCT, randomized controlled trials; 
TBI, traumatic brain injury; aAMSTAR-2 interpretations: High: no or one non- critical weakness, Moderate: more than one non-critical weakness, Low: one 
critical flaw with or without non-critical weaknesses, Critically low: more than one critical flaw with or without non-critical weaknesses; bAs reported in systematic review 
favours          favors 
intervention   control 
 
cII (Highly suggestive evidence): n>1000, P < 0.000001 for pooled estimate, largest study p<0.05; III (suggestive evidence): n>1000 and p<0.001 for pooled estimate; IV (weak evidence): p<0.05 for 
pooled estimate; NS (nonsignificant association): p>0.05 for pooled estimate; dNumber of studies ≥ 70% items; eAntiepileptic drugs were compared to either placebo, no treatment or other 
pharmacologic agents; fSeven RCTs at high risk of bias were excluded 
 
